Supplies of essential chemotherapy drugs are running low — and experts fear the situation could soon lead to rationing of cancer-treating medications, according to a report.
Doctors across the U.S. are seeing shortages due to shipping delays, manufacturing problems and some companies discontinuing medications, The New York Times reported, citing the Food and Drug Administration.
